Trinity Biotech (TRIB) Non-Current Assets (2016 - 2024)
Trinity Biotech (TRIB) has disclosed Non-Current Assets for 9 consecutive years, with $62.2 million as the latest value for Q4 2024.
- Quarterly Non-Current Assets rose 204.82% to $62.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $62.2 million through Dec 2024, up 204.82% year-over-year, with the annual reading at $62.2 million for FY2024, 204.82% up from the prior year.
- Non-Current Assets hit $62.2 million in Q4 2024 for Trinity Biotech, up from $20.4 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $62.2 million in Q4 2024 to a low of $20.4 million in Q4 2023.
- Historically, Non-Current Assets has averaged $44.3 million across 5 years, with a median of $46.2 million in 2021.
- Biggest five-year swings in Non-Current Assets: plummeted 55.11% in 2023 and later soared 204.82% in 2024.
- Year by year, Non-Current Assets stood at $47.1 million in 2020, then decreased by 1.89% to $46.2 million in 2021, then dropped by 1.67% to $45.4 million in 2022, then tumbled by 55.11% to $20.4 million in 2023, then skyrocketed by 204.82% to $62.2 million in 2024.
- Business Quant data shows Non-Current Assets for TRIB at $62.2 million in Q4 2024, $20.4 million in Q4 2023, and $45.4 million in Q4 2022.